Johnson on Gastroenterology

 
 
  • PPIs and Cardiac Risk: Unveiling the Mask of Truth   Dr David Johnson follows up on concerns about proton pump inhibitors and cardiovascular risk, setting the record straight.
  • PPIs and Cardiac Risk: Does It Pass the Sniff Test?   Dr David Johnson explains why he does not share the news media's concern about proton pump inhibitors and cardiovascular risk.
  • Keeping 'Tract': GI Updates From DDW 2015   Dr David Johnson provides a comprehensive review of the most interesting and intriguing topics that were presented at this year's Digestive Disease Week (DDW) meeting.
  • Rifaximin for IBS: Where Do We Stand?   Dr David Johnson reviews the latest data on rifaximin treatment for diarrhea-predominant irritable bowel syndrome.
  • Gauging Quality in Colonoscopy   Dr David Johnson takes you through the highlights of the new performance targets for quality colonoscopy -- from getting consent to reviewing results with patients.
  • Eosinophilic Esophagitis: No Steroids Needed?   A new understanding of the natural history of eosinophilic esophagitis suggests that endoscopic dilation and a dysphagia diet may be a better way to go in steroid-naive adult patients.
  • From HCV to EoE and IBD: Best of ACG 2014   Dr David Johnson takes you on a whirlwind tour of the practice-changing highlights from this year's American College of Gastroenterology meeting.
  • Colon Cleansing for Colonoscopy: New Guidelines   With products coming and going, what is the best preparation for bowel cleansing before colonoscopy?
  • Can Cologuard Improve Colon Cancer Screening Rates?   A new multitargeted stool-based screening test could be the answer for patients who avoid colonoscopy. Dr. David Johnson offers commentary, and a couple of caveats, on its use in clinical practice.
  • Get Ready for Chromoendoscopic Surveillance in IBD   Dr. David Johnson discusses a new paradigm for endoscopic colorectal cancer surveillance in patients with inflammatory bowel disease that spells the end for random biopsies.
  • The Debut of Vedolizumab for Inflammatory Bowel Disease   Dr. David Johnson discusses the newly approved drug for both ulcerative colitis and Crohn disease that more closely targets gut inflammation, and may be a boon for patients.
  • New Drugs, Diets, Diagnostics, and Therapeutic Techniques   Dr. David Johnson summarizes the practice-changing highlights from this year's Digestive Disease Week (DDW) meeting.
  • A Sneak Peek of DDW 2014   Dr. David Johnson highlights some of the most interesting and intriguing topics to be presented at this year's Digestive Disease Week (DDW) meeting in Chicago.
  • Fractured Sleep Exacts a Heavy Toll   There is increasing awareness of the adverse health implications of sleep deprivation/fragmentation. Could it play a role in cancer development and progression? Dr. David Johnson offers commentary.
  • Safety of Capsule Endoscopy With Implantable Cardiac Devices Capsule endoscopy is contraindicated in patients with implantable cardiac devices per the current recommendations. Is that still valid? Maybe not. Dr. David Johnson explores the latest evidence.
  • Top 10 Highlights From ACG 2013 Dr. David Johnson presents his top 10 key scientific presentations from this year's American College of Gastroenterology meeting in San Diego.
  • Probiotics for Diarrhea: Are 'Bug-Drugs' the Answer?   Can probiotics prevent antibiotic-associated diarrhea or C difficile diarrhea? Do they play a role in the prevention of other GI diseases? Dr. David Johnson offers commentary and clinical guidance.
  • Lymphocytic Esophagitis: Don’t Miss This   First eosinophilic esophagitis and now lymphocytic esophagitis -- Dr. David Johnson discusses how to recognize its characteristics and differentiate it from other esophageal diseases.
  • What Can We Do to Prevent Medical Malpractice?   Dr. David Johnson highlights advice from a world-renowned colonoscopist and skilled expert witness on how to avoid and defend against malpractice suits for postcolonoscopy cancer.
  • C difficile: Guidelines to Diagnose, Treat, and Prevent   Dr. David Johnson highlights the new guidelines on diagnosing, treating, and preventing Clostridium difficile infection, and provides guidance for the clinician toward application to daily practice.